Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-25T20:51:09.033Z Has data issue: false hasContentIssue false
  • English
  • Français

A Case of Creutzfeldt-Jakob Disease Associated With a Dura Mater Graft in the United States

Published online by Cambridge University Press:  02 January 2015

David B. Blossom ,
Ryan A. Maddox ,
Suzanne F. Beavers ,
Kelly A. Church ,
Doug A. Thoroughman ,
Lawrence B. Schonberger  and
Ermias D. Belay
David B. Blossom*
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia
Ryan A. Maddox
Affiliation:
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Suzanne F. Beavers
Affiliation:
Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia Kentucky Department for Public Health, Frankfort, Kentucky
Kelly A. Church
Affiliation:
Office of Workforce and Career Development, Centers for Disease Control and Prevention, Atlanta, Georgia
Doug A. Thoroughman
Affiliation:
Kentucky Department for Public Health, Frankfort, Kentucky
Lawrence B. Schonberger
Affiliation:
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Ermias D. Belay
Affiliation:
Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Centers for Disease Control and Prevention, 1600 Clifton Rd. MS-A35, Atlanta, GA30333 (dblossom@cdc.gov)
Get access Rights & Permissions [Opens in a new window]

Abstract

We describe a case of Creutzfeldt-Jakob disease associated with a dura mater graft (Lyodura brand) in a 26-year-old man who underwent several neurosurgical procedures as a child. Clinicians and infection control personnel should be aware that recipients of Lyodura brand dura mater grafts processed before May 1987 may remain at increased risk for Creutzfeldt-Jakob disease throughout their lives.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 12 , December 2007 , pp. 1396 - 1397
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Fradkin, JE, Schonberger, LB, Mills, JL, et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA 1991;265:880–884.CrossRefGoogle ScholarPubMed
2.Duffy, P, Wolf, J, Collins, G, Devoe, AG, Streeten, B, Cowen, D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974;290:692–693.Google ScholarPubMed
3.Bernoulli, C, Siegfried, J, Baumgartner, G, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977;1:478–479.Google Scholar
4.Hannah, EL, Belay, ED, Gambetti, P, et al. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001;56:1080–1083.Google Scholar
5.Brown, P, Brandel, JP, Preese, M, Sato, T. Iatrogenic Creutzfeldt-Jakob disease. Neurology 2006;67:389–393.CrossRefGoogle ScholarPubMed
6.Centers for Disease Control and Prevention. Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 1987;36:324–325.Google Scholar
7.Lane, KL, Brown, P, Howell, DN, et al. Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 1994;34 737–740Google Scholar
8.Centers for Disease Control and Prevention. Questions and answers: Creutzfeldt-Jakob disease infection-control practices. http://www.cdc.gov/ncidod/dvrd/cjd/qa_cjd_infection_control.htm. Accessed July 12, 2007.Google Scholar
9.Belay, ED, Schonberger, LB. The public health impact of prion diseases. Annu Rev Public Health 2005;26:191–212.Google Scholar